{'fraction_non_alphanumeric': 0.02699055330634278, 'fraction_numerical': 0.010121457489878543, 'mean_word_length': 5.962441314553991, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Antibacterial activity of cationic amphiphil conjugates with ciprofloxacin

The aim: Design and synthesis of new compounds with antibacterial activity. Determination of the minimum inhibitory and minimum bactericidal concentration of conjugates of cationic amphiphiles based on quaternary salts of 1,4-diazabicyclo[2.2.2]octane with ciprofloxacin. Materials and methods: The article is dedicated to the synthesis and primary assessment of antibacterial activity in vitro of conjugates of cationic amphiphiles based on quaternary salts of 1,4-diazabicyclo[2.2.2]octane with ciprofloxacin against gram-negative and gram-positive microorganisms. Results: The present work provides hybrid structures which include the widely used antibiotic ciprofloxacin and tetra-cationic DABCO derivatives. The last ones previously showed a wide spectrum of antimicrobial activity as well as primary studies of their antibacterial activity against gram-positive and gram-negative microorganisms in vitro. There was a high in vitro antibacterial activity against gram-negative pathogens, moderate against Staphylococcus aureus and low against Enterococcus faecalis. Conclusions: A range of amphiphilic polycationic compounds based on quaternary salts of 1,4-diazabicyclo[2.2.2]octane (DABCO) was synthesized and their biological activity was studied. The compounds have demonstrated high antibacterial activity. We assume that they can serve as a basis for the development of new antibacterial drugs. 